Neil Exter - Profile and Investment Details

Investor Profile

Neil Exter is a Venture Capital, Investor, Private Equity Firm based in Lexington, Massachusetts, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus Therapeutics, PanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica Pharmaceuticals, Cibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, Lotus Tissue Repair, Bluebird Bio, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint Medical, Asher Bio, MyoKardia, Thrive Earlier Detection, Celsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Revolution Medicines, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals. Over time, Neil Exter has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Neil Exter is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Medical Testing, Women Led, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Neil Exter, as their portfolio suggests a familiarity and interest in this area.

Understanding Neil Exter’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.